InspireMD (NASDAQ:NSPR) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 6th. Analysts expect the company to announce earnings of ($2.00) per share for the quarter.
InspireMD (NASDAQ:NSPR) last issued its earnings results on Tuesday, May 14th. The company reported ($3.82) earnings per share for the quarter, missing the consensus estimate of ($2.50) by ($1.32). The business had revenue of $0.42 million during the quarter, compared to the consensus estimate of $1.10 million.
NSPR stock traded down $0.13 during mid-day trading on Friday, hitting $3.17. The stock had a trading volume of 2,958 shares, compared to its average volume of 134,008. InspireMD has a 1-year low of $3.00 and a 1-year high of $15.35. The business’s fifty day moving average price is $3.37.
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.
Recommended Story: How to calculate the intrinsic value of a stock
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.